Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2005

01-02-2005 | Original Article

Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients

Authors: D. Violot, R. M’kacher, E. Adjadj, J. Dossou, F. de Vathaire, C. Parmentier

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2005

Login to get access

Abstract

Purpose

The aim of this study was to evaluate the frequency of chromosomal abnormalities in thyroid cancer patients before and after radioactive iodine administration in order to assess cytogenetic particularity in Polynesian thyroid cancer patients.

Methods

Chromosomal abnormalities were studied in 30 Polynesian patients with differentiated thyroid cancer, prior to and 4 days after 131I administration. Unstable chromosomal abnormalities were counted in peripheral blood lymphocytes using a conventional cytogenetic method. Peripheral blood was irradiated in vitro at different doses (0.5, 1 and 2 Gy) in order to establish the dose-response of the lymphocytes. Control groups were composed of 50 European thyroid cancer patients before and after first administration of 131I, and of ten European healthy donors. In addition, in vitro irradiation assays were performed at different doses (0.5, 1 and 2 Gy).

Results

The relative risk of spontaneous dicentrics before any radiation treatment was 2.9 (95% CI 1.7–5.1) times higher among Polynesian thyroid patients than among European thyroid cancer patients. After in vitro irradiation, the rise in frequency of dicentrics was similar in the Polynesian thyroid cancer group and the European thyroid patients and healthy donors. Four days after administration of 3.7 GBq 131I, the relative risk for a dicentric per cell was 1.3 (95% CI 1.0–1.5) times higher in Polynesian than in European patients. This can be explained by higher 131I retention in Polynesian compared with European patients. The results obtained revealed an increased frequency of cytogenetic abnormalities in Polynesian thyroid cancer patients compared with European control patients.

Conclusion

These preliminary findings are compatible with possible previous environmental aggression and therefore imply a need for further investigations on larger series including, in particular, French Polynesian healthy donors. In addition to French Polynesians, Maori and Hawaiian control groups could be useful.
Literature
1.
go back to reference Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, vol VII, IARC Scientific Publications No. 143. Lyon: IARC; 1997. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J. Cancer incidence in five continents, vol VII, IARC Scientific Publications No. 143. Lyon: IARC; 1997.
2.
go back to reference de Vathaire F, Le Vu B, Vathaire CC. Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974. Cancer Causes Control 2000;11:59–63.CrossRefPubMed de Vathaire F, Le Vu B, Vathaire CC. Thyroid cancer in French Polynesia between 1985 and 1995: influence of atmospheric nuclear bomb tests performed at Mururoa and Fangataufa between 1966 and 1974. Cancer Causes Control 2000;11:59–63.CrossRefPubMed
4.
go back to reference Anderson D, Francis AJ, Godbert P, Jenkinson PC, Butterworth KR. Chromosome aberrations (CA), sister-chromatid exchanges (SCE) and mitogen-induced blastogenesis in cultured peripheral lymphocytes from 48 control individuals sampled 8 times over 2 years. Mutat Res 1991;250:467–76. DOI 10.1016/0027-2107(91)90203-ZCrossRefPubMed Anderson D, Francis AJ, Godbert P, Jenkinson PC, Butterworth KR. Chromosome aberrations (CA), sister-chromatid exchanges (SCE) and mitogen-induced blastogenesis in cultured peripheral lymphocytes from 48 control individuals sampled 8 times over 2 years. Mutat Res 1991;250:467–76. DOI 10.​1016/​0027-2107(91)90203-ZCrossRefPubMed
5.
go back to reference M’Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, Parmentier C. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1996;37(11):1860–4.PubMed M’Kacher R, Legal JD, Schlumberger M, Voisin P, Aubert B, Gaillard N, Parmentier C. Biological dosimetry in patients treated with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1996;37(11):1860–4.PubMed
6.
go back to reference Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 2000;463:111–72. DOI 10.1016/S1383-5742(00)00049-1CrossRefPubMed Albertini RJ, Anderson D, Douglas GR, Hagmar L, Hemminki K, Merlo F, et al. IPCS guidelines for the monitoring of genotoxic effects of carcinogens in humans. International Programme on Chemical Safety. Mutat Res 2000;463:111–72. DOI 10.​1016/​S1383-5742(00)00049-1CrossRefPubMed
8.
go back to reference Evans HJ, Buckton KE, Hamilton GE, Carothers A. Radiation-induced chromosome aberrations in nuclear-dockyard workers. Nature 1979;277:531–4.PubMed Evans HJ, Buckton KE, Hamilton GE, Carothers A. Radiation-induced chromosome aberrations in nuclear-dockyard workers. Nature 1979;277:531–4.PubMed
10.
go back to reference Cigarran S, Barquinero J-F, Barrios L, Ribas M, Egozcue J, Caballin M-R. Cytogenetic analyses by fluorescence in situ hybridization (FISH) in hospital workers occupationally exposed to low levels of ionizing radiation. Radiat Res 2001;155:417–23.PubMed Cigarran S, Barquinero J-F, Barrios L, Ribas M, Egozcue J, Caballin M-R. Cytogenetic analyses by fluorescence in situ hybridization (FISH) in hospital workers occupationally exposed to low levels of ionizing radiation. Radiat Res 2001;155:417–23.PubMed
11.
go back to reference Baugnet-Mahieu L, Lemaire M, Leonard E-D, Leonard A, Gerber G-B. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 1994;140:429–31.PubMed Baugnet-Mahieu L, Lemaire M, Leonard E-D, Leonard A, Gerber G-B. Chromosome aberrations after treatment with radioactive iodine for thyroid cancer. Radiat Res 1994;140:429–31.PubMed
12.
go back to reference Finnon P, Moquet JE, Edwards AA, Lloyd DC. The 60Co gamma ray dose-response for chromosomal aberrations in human lymphocytes analysed by FISH; applicability to biological dosimetry. Int J Radiat Biol 1999;75:1215–22. DOI 10.1080/095530099139368CrossRefPubMed Finnon P, Moquet JE, Edwards AA, Lloyd DC. The 60Co gamma ray dose-response for chromosomal aberrations in human lymphocytes analysed by FISH; applicability to biological dosimetry. Int J Radiat Biol 1999;75:1215–22. DOI 10.​1080/​095530099139368CrossRefPubMed
13.
go back to reference Durante M, Bonassi S, George K, Cucinotta FA. Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res 2001;156:662–7.PubMed Durante M, Bonassi S, George K, Cucinotta FA. Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res 2001;156:662–7.PubMed
14.
go back to reference Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1981. Breslow NE, Day NE. Statistical methods in cancer research. Vol 1. The analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1981.
15.
go back to reference Venzon DJ, Moolgavkar SH. A method for computing profile-likelihood-based confidence intervals. Appl Stat 1988;37:87–94. Venzon DJ, Moolgavkar SH. A method for computing profile-likelihood-based confidence intervals. Appl Stat 1988;37:87–94.
16.
go back to reference Bauchinger M. Quantification of low-level radiation exposure by conventional chromosome aberration analysis. Mutat Res 1995;339:177–89.CrossRefPubMed Bauchinger M. Quantification of low-level radiation exposure by conventional chromosome aberration analysis. Mutat Res 1995;339:177–89.CrossRefPubMed
17.
go back to reference Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000;60(6):1619–25.PubMed Bonassi S, Hagmar L, Stromberg U, Montagud AH, Tinnerberg H, Forni A, et al. Chromosomal aberrations in lymphocytes predict human cancer independently of exposure to carcinogens. European Study Group on Cytogenetic Biomarkers and Health. Cancer Res 2000;60(6):1619–25.PubMed
19.
go back to reference Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single strand breaks in DNA. Carcinogenesis 2004;25(5):757–63.CrossRefPubMed Vodicka P, Kumar R, Stetina R, Sanyal S, Soucek P, Haufroid V, et al. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single strand breaks in DNA. Carcinogenesis 2004;25(5):757–63.CrossRefPubMed
24.
go back to reference Wang LE, Bondy ML, de Andrade M, Strom SS, Wang X, Sigurdson A, et al. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res 2000;154:20–7.PubMed Wang LE, Bondy ML, de Andrade M, Strom SS, Wang X, Sigurdson A, et al. Gender difference in smoking effect on chromosome sensitivity to gamma radiation in a healthy population. Radiat Res 2000;154:20–7.PubMed
25.
go back to reference M’Kacher R, Légal JD, Schlumberger M, Aubert B, Béron-Gaillard N, Gaussen A, Parmentier C. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1997;38:377–80.PubMed M’Kacher R, Légal JD, Schlumberger M, Aubert B, Béron-Gaillard N, Gaussen A, Parmentier C. Sequential biological dosimetry after a single treatment with iodine-131 for differentiated thyroid carcinoma. J Nucl Med 1997;38:377–80.PubMed
Metadata
Title
Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients
Authors
D. Violot
R. M’kacher
E. Adjadj
J. Dossou
F. de Vathaire
C. Parmentier
Publication date
01-02-2005
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2005
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-004-1662-2

Other articles of this Issue 2/2005

European Journal of Nuclear Medicine and Molecular Imaging 2/2005 Go to the issue